NAD+ IV vs injection

One is a session in a chair with a nurse attached to it, priced per session and dosed per session. The other is a vial and a box of syringes you use at home, priced per month and dosed per dose. Both are sold as NAD+. Neither price means anything next to the other until you have the milligrams and the cycle for both.

What each one is actually buying

The drip

Chair time, a nurse, the consumables, and a room to sit in for as long as it takes. The NAD+ is a line item inside a service. That is why a single session can cost more than a month of the other thing without either figure being unreasonable — they are not paying for the same list.

The injection

A vial, syringes, and usually a consult wrapped into a subscription. The labor is yours. What you are buying is the drug, the fulfillment and the prescription, and the supervision line is simply not on the invoice because it is not in the product.

The comparison trap

A clinic quotes per session. A telehealth seller quotes per month. Put those two figures side by side and you are comparing a unit price to a subscription, which tells you nothing. To compare them at all you need three things from each seller, and a surprising number of pages give you one or two:

• Milligrams per dose or per session. The unit the product is actually sold in.
• How many of those the price covers. One session, or eight doses in a month, or a package of six bought up front.
• The billing cycle, in the seller’s own words. Per session, per month, per package. A “from” figure is a floor, not a rate, and the two are printed differently on this site’s board for that reason.

With all three you can put both sellers on the same denominator. Without them you are guessing, and the guess will usually favor whoever wrote the larger number in the smaller font. The board on the home page carries the route, the milligrams and the cycle for every row precisely so this arithmetic is possible.

The claim this page will not make

Sellers on both sides argue that their route delivers more of what you paid for. IV pages point at going straight into a vein; subcutaneous pages point at steadier exposure over a week. Those are claims about what reaches circulation and how quickly, they are the load-bearing claims in the entire category, and this site has not sourced them. [needs citation] So it does not repeat them, in either direction, and you should treat a seller that states one as a fact without a citation the way you would treat any other unsourced number on a checkout page.

What can be said without a source is duller and more useful: the two routes differ in who is in the room, how often you do it, what happens if something feels wrong, and what the invoice covers. Those differences are real, checkable on the seller’s own pages, and they are usually enough to decide.

Where the nasal spray and the capsule sit

Two more things get sold into the same search results. A nasal spray,which is a third route and which 15 of the 24 sellers on this roster with a nasal row price without ever saying how many milligrams a spray delivers. And an oral capsule of NMN or NR, which is a precursor the body converts rather than NAD+ itself — a different molecule, a legitimate category, and not the thing an IV-versus-injection comparison is about. This site keeps the capsule on the same board, marked, so that its price is never quietly read as a cheaper version of the drip.

How to choose without a clinical claim

You are picking a delivery model before you are picking a molecule. A drip is an appointment: someone else handles it, you travel to it, you pay per occasion. An at-home injection is a routine: you handle it, it is cheaper per occasion, and the responsibility for noticing a problem is yours. Which of those two you can actually sustain for three months is a better predictor of how this goes than anything on either seller’s landing page.

This is not medical advice. Nobody here is a clinician, this site runs no clinical review, and none of it should be read as a recommendation to take or avoid anything. Decisions about NAD+ belong with a licensed clinician who has your history in front of them.

The other 15

• NAD+ injection side effects

  Which questions are worth asking depends on the route, and on whether the seller states a dose at all.

• How often you take NAD+

  Frequency is usually a billing cadence before it is a clinical one. Here is how to tell which you are looking at.

• The nine routes

  NAD+ is sold nine ways and a third of the sellers on this roster name none of them. The whole census, both denominators, and what our reading had to move.

• “Route not stated”

  The second largest group on the roster is the sellers who did not say. Some wrote nothing; others wrote a sentence that still is not a route. Every one of those sentences.

• Sublingual NAD+ and precursors

  Two different molecules are sold under one word. Our own reading pass filed 18 of 26 on the wrong side of it before review.

• What a NAD+ price includes

  Most figures never say what is in the number, and whether a seller tells you depends on the route. What this roster can say, and the one thing it cannot.

• NAD+ price by route

  Is the spray cheaper than the injection? Fifteen sellers price both, and they do not agree with each other.

• Sellers that sell NAD+ more than one way

  A brand offering NAD+ two ways is offering two purchases at two prices. How many do, which routes travel together, and how many never say.

• Who states the milligrams

  A price without a dose is not comparable. The nasal sellers state milligrams more often than the injection sellers do, and the routeless figures state them least.

• How a route is billed

  Not one figure for the two routes that need a clinic is a standing monthly rate. Sublingual is the weekly route. What kind of number each route publishes.

• When the URL names a route

  A seller's own address is the first route claim a buyer meets. “Nasal” meant nasal every time. “Oral” never once meant the precursor a reader would expect.

• Pages that publish no price

  The most common outcome of opening a NAD+ product page is not a number. What the silent ones did instead, and the one signal that predicted them in advance.

• Prices in the markup

  Most NAD+ pages carry dollar amounts you are not shown. Why that is a reason to open the toggles and not an accusation — with the control that bounds it.

• The price behind the intake

  “They don’t publish a price” is only honest if you clicked the button. Thirty-three sellers were followed one click past the page. Almost none of it was a price.

• Pages that price two routes

  Where a spray and a needle are sold in one grid, a route choice looks like a price choice. Which routes get sold side by side, and how deep it goes.